Risk of embolization after institution of antibiotic therapy for infective endocarditis
Isidre Vilacosta, MD*,*,
Catherine Graupner, MD*,
JoséAlberto SanRomán, MD ,
Cristina Sarriá, MD ,
Ricardo Ronderos, MD ,
Cristina Fernández, MD*,
Leonardo Mancini, MD ,
Olga Sanz, MD ,
JuanVictor Sanmartín, MD and
Walter Stoermann, MD||
* Hospital Universitario San Carlos, Madrid, Spain
Hospital Universitario de Valladolid, Valladolid, Spain
Hospital de la Princesa, Madrid, Spain
Hospital San Juan de Dios, La Plata, Argentina
|| CIMAC, San Juan, Argentina

View larger version (16K):
[in a new window]
|
Figure 1 Risk of embolism stratified by the location of infection. Ao = native aortic valve; Ao. Biol = biologic aortic prosthesis; Ao. Mech = mechanical aortic prosthesis; Mi = native mitral valve; Mi. Biol = biologic mitral prosthesis; Mi. Mech = mechanical mitral prosthesis.
|
|

View larger version (17K):
[in a new window]
|
Figure 2 Risk of embolism stratified by location of infection, valve type and mitral leaflet.
|
|

View larger version (17K):
[in a new window]
|
Figure 3 Risk of embolism stratified by vegetation size. CI = confidence interval; RR = relative risk.
|
|
|